Search results
Results From The WOW.Com Content Network
The FTC complaint also states that the company's former owners and founders, Victoria Knight-McDowell and Thomas John McDowell, "made false claims that Airborne products are clinically proven to treat colds." [5] Shortly after the settlements, a new management team was brought in to run the company.
Juice Plus is a branded line of dietary supplements. It is produced by Natural Alternatives International of San Marcos, California, for National Safety Associates (NSA; Collierville, Tennessee). Introduced in 1993, [4] the supplements are distributed by NSA via multi-level marketing. Juice Plus supplements contain fruit and vegetable juice ...
NAD+ supplements, IV drips, and injections have gained a lot of traction on social media due to their supposed anti-aging benefits. Here, doctors reveals the truth behind the trend.
As of 2011, reviews concluded that when oseltamivir is used preventatively it decreases the risk of exposed people developing symptomatic disease. [30] [41] A systematic review of systematic reviews found low to moderate evidence that it decreases the risk of getting symptomatic influenza by 1 to 12% (a relative decrease of 64 to 92%). [12]
In 2013, the marketers of Sensa paid US$905,000 (equivalent to $1,183,740 in 2023) to settle false advertising charges in California after an investigation by the Statewide Nutritional Supplement Task Force determined they were making unsubstantiated claims regarding the efficacy of their products and making unauthorized charges to customers.
The Bronson Bacopa 1200 MG supplement is made with pure and potent extract, providing optimal potency and bioavailability. With consistent use, it may help support mental focus, clarity and ...
This article originally appeared on Bucks County Courier Times: Pa. law shielding teacher misconduct complaints ruled unconstitutional Show comments Advertisement
[35] Another review assessed the quality of evidence for alternative influenza treatments, it concluded that there was "no compelling evidence" that any of these treatments were effective and that the available data on these products is particularly weak, with trials in this area suffering from many shortcomings, such as being small and poorly ...